Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMC Cancer|February 13, 2014
Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasisJoelle M Fenger, Misty D Bear, Stefano Volinia, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
The Journal of Clinical Investigation|November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppressionShuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
Blood|September 7, 2013
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homingJason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, et al.
Leukemia & Lymphoma|March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphomaBonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
International Immunology|June 6, 2018
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemiaNathaniel J Buteyn, Kavin Fatehchand, Ramasamy Santhanam, et al.
Blood Advances|January 4, 2018
BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemiaYo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell LymphomaFabienne Lucas, Kerry A Rogers, Bonnie K Harrington, et al.
Plos One|July 20, 2016
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin LymphomaBonnie K Harrington, Heather L Gardner, Raquel Izumi, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Pageof 2